Avalere Health Group

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Avalere Health Group - overview

Established

2001

Location

-, Cheshire, UK

Primary Industry

Marketing/Advertising

About

Avalere Health Group is a UK-based company specializing in advisory, medical, and marketing solutions tailored for the healthcare industry, helping clients navigate complex market dynamics effectively. Founded in 2001, Avalere Health Group operates as a healthcare consultancy providing strategic guidance and solutions for clients in the pharmaceutical, payer, and provider sectors. The company is headquartered in the UK and has engaged in 5 total deals. Recently, it raised GBP 18.


5 million in a Growth round from investor LDC, bringing its total amount raised to GBP 18. 5 million. Avalere Health offers a comprehensive suite of services primarily focused on advisory, medical, and marketing solutions tailored for the healthcare industry. Their advisory services involve the development of agile strategies that adapt to evolving industry trends, ensuring optimal outcomes for patients.


The medical division creates engaging narratives that translate scientific data into actionable insights for healthcare professionals, while the marketing team specializes in building authentic brands and crafting meaningful interactions for healthcare consumers. Avalere serves a diverse client base, including pharmaceutical companies, healthcare providers, and payers across North America, Europe, and Asia-Pacific, utilizing its proprietary strategic model, Sense Making, to bridge gaps in healthcare access. In the most recent fiscal year, Avalere Health reported a revenue of GBP 407,540,000 with an EBITDA of GBP -6,493,000, reflecting the revenues generated through long-term contracts with pharmaceutical companies, healthcare organizations, and payers, structured around tailored service agreements. Avalere Health Group aims to utilize the GBP 18.


5 million raised in their recent Growth funding to extend its operations into North America. The company is focusing on the development of new products and enhancing existing services to meet the needs of clients in this target region, with strategic plans expected to be executed in the coming year.


Current Investors

Bridgepoint Group, LDC

Primary Industry

Marketing/Advertising

Sub Industries

Consulting Services, Public Relations & Communications, eMarketing/Digital Marketing, Outsourcing, Healthcare

Website

www.fishawack.com

Company Stage

Mature

Total Amount Raised

Subscriber access only

Avalere Health Group - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Add-onCompletedCloserlook LLC-
Add-onCompletedPRMA Consulting Limited-
Add-onCompletedSkysis, LLC-
Secondary BuyoutCompletedAvalere Health Group-
Add-onCompleted2e Creative, Inc.-

Displaying 1 - 5 of 17

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.